BioXcel Therapeutics (BTAI) Selling, General & Administrative (2017 - 2026)
Powered by 
Analysis
BioXcel Therapeutics (BTAI) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | 165.53 Mn |
| 10 | BioXcel Therapeutics | 2.19 Mn | 2.19 Mn | 160,000.00 | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.19 Mn |
| Mar 31, 2026 | 7.19 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 5.61 Mn |
| Mar 31, 2025 | 5.70 Mn |
| Dec 31, 2024 | 4.09 Mn |
| Sep 30, 2024 | 7.68 Mn |
| Jun 30, 2024 | 9.45 Mn |
| Mar 31, 2024 | 13.26 Mn |
| Dec 31, 2023 | 9.60 Mn |
| Sep 30, 2023 | 24.34 Mn |
| Jun 30, 2023 | 25.87 Mn |
| Mar 31, 2023 | 23.60 Mn |
| Dec 31, 2022 | 20.66 Mn |
| Sep 30, 2022 | 17.05 Mn |
| Jun 30, 2022 | 18.38 Mn |
| Mar 31, 2022 | 12.92 Mn |
| Dec 31, 2021 | 13.61 Mn |
| Sep 30, 2021 | 14.88 Mn |